Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat.
Transient receptor ion channel 1 (TRPV1) is a nociceptor involved in visceral hypersensitivity. Aminoglycosides like neomycin are not only potent antibiotics but in vitro data suggest that neomycin also acts as a TRPV1-antagonist and alleviates somatic pain responses. To what extent neomycin reduces visceral hypersensitivity remains unknown. Therefore, we aimed to investigate whether neomycin can inhibit in vivo TRPV1-dependent hypersensitivity responses in two rat models of visceral pain. In the first model rats were pretreated with intraperitoneal (i.p.) capsazepine, the selective TRPV1 antagonist SB-705498, neomycin or vehicle alone and 30 min later instilled with intracolonic TRPV1-activating capsaicin. Likewise, rats were pretreated with 10 days oral neomycin and then subjected to intracolonic capsaicin. The visceromotor response (VMR) to distension was measured before and after capsaicin application. In addition, the VMR to distension was measured in adult maternal separated rats before and after acute stress. Before the 2nd distension protocol these rats were treated with i.p. neomycin, amoxycillin or vehicle alone. Our results showed that capsaicin administration induced an enhanced VMR to distension that was prevented by i.p. capsazepine, SB-705498 and neomycin. Oral neomycin treatment changed bacterial faecal content but could not inhibit capsaicin induced visceral hypersensitivity. In maternal separated rats acute stress induced an enhanced response to distension that was reversed by i.p. neomycin, but not amoxycillin. These data indicate that (i.p.) neomycin can inhibit visceral hypersensitivity to distension in a nonbactericidal manner and suggest that TRPV1-modulation may be involved.
van den Wijngaard
R M
RM
Academic Medical Center, Amsterdam, The Netherlands. R.vandenWijngaard@AMC.UVA.NL
Welting
O
O
Bulmer
D C
DC
Wouters
M M
MM
Lee
K
K
de Jonge
W J
WJ
Boeckxstaens
G E
GE
D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D003106:Colon / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D004106:Dilatation / Q000009:adverse effects; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D009355:Neomycin / Q000494:pharmacology*; D010146:Pain / Q000139:chemically induced; D011247:Pregnancy; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D018689:Sensory System Agents / Q000494:pharmacology; D050916:TRPV Cation Channels / Q000235:genetics / Q000378:metabolism*; D017833:Visceral Afferents / Q000187:drug effects*
D011500:Protein Synthesis Inhibitors; D018689:Sensory System Agents; D050916:TRPV Cation Channels; C493922:Trpv1 protein, rat; D009355:Neomycin; D002211:Capsaicin